During the past decade, Limited Liability Company "MedPomosch" conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Limited Liability Company "MedPomosch"" #1 sponsor was "Kowa Research Institute, Inc." with 2 trials, followed by "Materia Medica Holding" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Clovis Oncology, Inc." with 1 trials sponsored and "RSV Therapeutics LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Limited Liability Company "MedPomosch"" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Foundation Medicine" with 1 trials as a collaborator and "Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Limited Liability Company "MedPomosch"" are "Cardiovascular Disease" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Anxiety" (1 trials), "COVID-19" (1 trials) and "Cerebral Atherosclerosis" (1 trials). Many other conditions were trialed in "Limited Liability Company "MedPomosch"" in a lesser frequency.

Most popular intervention types in "Limited Liability Company "MedPomosch"" are "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Limited Liability Company "MedPomosch"" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Limited Liability Company "MedPomosch"". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Limited Liability Company "MedPomosch", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Limited Liability Company "MedPomosch", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".